Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Acta Pharmaceutica Sinica ; (12): 1808-1815, 2022.
Article in Chinese | WPRIM | ID: wpr-929432

ABSTRACT

To investigate the effect of Fufang yinhua jiedu (FFYH) granules against coronavirus and its potential mechanism, we used Huh7, Huh7.5, H460, and C3A cell lines as in vitro models to evaluate the cytotoxicity and antiviral activity of FFYH by observation of cell pathogenic effect (CPE); and then the inhibitory effect of FFYH on the transcription expression of coronavirus RNA and inflammatory factor mRNA were evaluated by quantitive reverse transcription PCR (qRT-PCR); finally, the inhibitory effect of FFYH on the expression of coronavirus protein and its underlying mechanism against coronavirus were investigated by Western blot and immunofluorescence. Our results indicated that 50% toxic concentration (TC50) FFYH on Huh7, Huh7.5, H460, and C3A cells were 2 035.21, 5 245.69, 2 935.28 and 520 µg·mL-1, respectively; 50% inhibitory concentration (IC50) of FFYH on HCoV-229E in Huh7 and Huh7.5 cells were 438.16 and 238.54 µg·mL-1 with safety index (SI) of 4.64 and 21.99, respectively; IC50 of FFYH on HCoV-OC43 in H460 cells was 165.13 µg·mL-1 with SI of 17.78. Moreover, FFYH not only could inhibit the replication of coronaviruses (HCoV-OC43 and HCoV-229E) through inhibiting the transcription of viral RNA and the expression of viral protein, but also effectively suppress the expression of inflammatory factors interleukin-6 (IL-6), tumor necrosis factor α (TNF-α) and interleukin-8 (IL-8) at mRNA level caused by coronaviruses, which might be associated with the inhibitory effect of FFYH on mitogen-activated protein kinase (MAPK) pathway and the nuclear translocation of nuclear transcription factor-κB (NF-κB). In summary, our results demonstrated that FFYH exhibited a good in vitro anti-coronavirus effect, which provides a theoretical basis for its clinical use in the treatment of anti-coronavirus pneumonia.

2.
Journal of Kunming Medical University ; (12): 144-148, 2018.
Article in Chinese | WPRIM | ID: wpr-694609

ABSTRACT

Objective To investigate the effect of the family nursing intervention on treatment of children with asthma, and explore the effect of family nursing intervention on the pulmonary function and quality of life in asthmatic children. Methods A total of 260 children with asthma were recruited at the First Affiliated Hospital of Xi'an Jiaotong University from July 2012 to July 2015. They were randomly divided into observation and control groups with 130 cases in each group. The control group were given routine nursing and regular treatment, and the observation group were received additional family nursing intervention management at the same time. We use Pediatric Asthma Quality of Life Questionnaire (PAQLQ) and pulmonary function testing to evaluate the influence of family nursing intervention on treatment effect and quality of life of asthmatic children. Results The total effective rate was 93% in the observation group and was 65% in the control group (P<0.05) . The pulmonary function and quality of life were significant higher in the intervention group compared with the control group after intervention. Parents’satisfaction was significantly higher in the intervention group (P<0.05) . Conclusion Family nursing intervention is an effective mode of management of children with asthma that can obviously improve pulmonary function and quality of life of asthmatic children. Moreover, family nursing intervention also contributes to raising parents'satisfaction.

3.
Journal of Experimental Hematology ; (6): 1193-1198, 2014.
Article in Chinese | WPRIM | ID: wpr-302321

ABSTRACT

This study was aimed to investigate the expression of biomarkers (PTEN, mTOR, NF-kB, CD44, PI3K) related with bone marrow cells in patients with acute myelogenous leukemia. The immunohistochemical method was used to detect the expression of PTEN, mTOR, NF-kB, CD44, PI3K in 20 patients. The AML patients were divided into remission group and non-remission group after calculating the percentage of leukemia cells in bone marrow. The results showed that by optical microscopy, the positive expression rates of PTEN, mTOR, NF-kB, CD44 and PI3K in remission group were 33.3%, 33.3%, 77.8%, 22.2%, 0, respectively; meanwhile, in non-remission group, the positive expression rates of above-menthioned biomarkers were 63.6%, 18.2, 90.9, 63.6%, 0, respectively. The percentage and mean OD for PTEN and CD44 were statistically different between the two groups (P < 0.05), but for mTOR, NF-kB and PI3K were not statistically differenly (P > 0.05). It is concluded that the high expression of PTEN and CD44 can be regarded as an important index for diagnosis and prognosis in acute myelogenous leukemia.


Subject(s)
Humans , Biomarkers , Bone Marrow Cells , Chemistry , Leukemia, Myeloid, Acute , Diagnosis , NF-kappa B , PTEN Phosphohydrolase , Phosphatidylinositol 3-Kinases , Prognosis , TOR Serine-Threonine Kinases
4.
Chinese Journal of Contemporary Pediatrics ; (12): 678-682, 2012.
Article in Chinese | WPRIM | ID: wpr-353890

ABSTRACT

<p><b>OBJECTIVE</b>To explore the method for early diagnosis and pathogenesis of MYH9-related syndrome through analysis of the clinical manifestation and gene mutation of a Chinese family with MYH9-related syndrome.</p><p><b>METHODS</b>Peripheral blood samples were collected from a three-generation Chinese family with MYH9-related syndrome (11 individuals, including 3 patients) and 100 healthy individuals. Polymerase chain reaction (PCR) amplification and direct sequencing of DNA were performed to analyze mutations of MYH9 gene.</p><p><b>RESULTS</b>Thrombocytopenia, increased volume of platelet, and granulocyte inclusion bodies were found in the patients with MYH9-related syndrome via a peripheral blood test. A missense mutation of a base pair (G-A) in exon 30 was revealed by PCR amplification and direct sequencing of MYH9 of the proband. That lead to Asp-Asn substitution at position 1424 (D1424N mutation). The mutation was the same as in other patients with MYH9-related syndrome. It was not found in healthy people from the Chinese family or in the other 100 healthy individuals.</p><p><b>CONCLUSIONS</b>Patients with MYH9-related syndrome show diverse symptoms. Mutation of MYH9 gene may be the molecular mechanism of MYH9-related syndrome, and D1424N mutation of MYH9 has not been reported in Chinese people. Early diagnosis of MYH9-related syndrome can be carried out by investigating family history and making early examinations.</p>


Subject(s)
Adult , Aged , Child, Preschool , Female , Humans , Asian People , Genetics , Molecular Motor Proteins , Genetics , Mutation , Myosin Heavy Chains , Genetics , Thrombocytopenia , Genetics
5.
Chinese Journal of Experimental and Clinical Virology ; (6): 269-271, 2008.
Article in Chinese | WPRIM | ID: wpr-254085

ABSTRACT

<p><b>OBJECTIVE</b>Anti-influenza virus activity of "Benovoair Concentrate".</p><p><b>METHODS</b>The different dilution of samples were mixed with the same quantity of 100 TCID50 virus at 37 degrees C for 30 minutes. Add suitable quantity mixture in wells containing cells. Every 3 wells were the same mode. Viruses control, cells control and samples control of different dilution were performed and set in the CO2 incubator at 37 degrees C. CPE was observed every day. When CPE appears in viruses control as "++++", stopped testing and performed the hemagglutination titration.</p><p><b>RESULTS</b>"Benovoair Concentrate" with dilution of 1:60, 1:120, 1:240 and 1:480 have 100% anti-influenza A and anti-influenza B activities. "Benovoair Concentrate" with dilution of 1:960 and 1:1920 have 25%-50% anti-influenza A and anti-influenza B activities.</p><p><b>CONCLUSION</b>The test was the proof of anti-influenza virus activities which provided for the development of "Benovoair Concentrate".</p>


Subject(s)
Animals , Dogs , Air Microbiology , Cell Line , Drugs, Chinese Herbal , Pharmacology , Oils, Volatile , Pharmacology , Orthomyxoviridae , Plant Oils , Pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL